Gene-Disorder Association · Article
Gene
KRAS KRAS Proto-Oncogene, GTPase
×
First reported
1997
Supporting publications
77
Manually curated Approved treatment annotated
Association Review
In brief The association between KRAS (KRAS Proto-Oncogene, GTPase) and Lung Non-Small Cell Carcinoma is well established and manually curated, with its 2 contributing sources — 1 of them expert-curated — recording pathogenic variants.
Sources
2
Clinical variants
18
Symptoms
0
Compounds
20
Trials
2,650 of 14,802 via KRAS compounds
Publications
77
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 2 sources
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
2 source summaries
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Lung Non-Small Cell Carcinoma
The disorder 6 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
ClinVar and variant evidence
Genetic basis 18 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
06
Mechanism overlap
Shared mechanisms 1 shared pathway
Biological pathways and phenotype concepts shared by the gene and the disorder, with supporting publications.
Request access
07
Interventions
Therapeutics 20 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
08
Human studies
Clinical trials 14,802 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
77 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
10
Provenance
References & sources 22 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access